Geovax Labs Stock (NASDAQ: GOVX) stock price, news, charts, stock research, profile.
Open | $3.47 |
Close | $3.19 |
Volume / Avg. | 19.82M / 2.35M |
Day Range | 3.01 - 4.54 |
52 Wk Range | 0.25 - 10.24 |
Market Cap | $7.64M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 62 |
Short Interest | 4.38% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Geovax Labs (NASDAQ:GOVX) through any online brokerage.
Other companies in Geovax Labs’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Virios Therapeutics (NASDAQ:VIRI), Dominari Holdings (NASDAQ:DOMH), Imunon (NASDAQ:IMNN) and Addex Therapeutics (NASDAQ:ADXN).
There is no analysis for Geovax Labs.
Geovax Labs has a consensus price target of $28.40.
The stock price for Geovax Labs (NASDAQ: GOVX) is $3.02 last updated June 28, 2024 at 7:59 PM EDT.
There are no upcoming dividends for Geovax Labs.
Geovax Labs’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Geovax Labs.
Geovax Labs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.